Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endothelial Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Post-approval studies (Phase 4)WithdrawnNCT04075136
What this trial is testing

Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Who this might be right for
Exudative Age Related Macular Degeneration
Wake Forest University Health Sciences
Not applicableStudy completedNCT05678517
What this trial is testing

Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD

Who this might be right for
Age-Related Macular Degeneration
Semmelweis University 47
Testing effectiveness (Phase 2)Study completedNCT02118831
What this trial is testing

Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF

Who this might be right for
Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
California Retina Consultants 56
Early research (Phase 1)Study completedNCT00659555
What this trial is testing

Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops

Who this might be right for
Macular Degeneration
GlaxoSmithKline 24
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Not applicableStudy completedNCT00727753
What this trial is testing

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
University of Zurich 54
Post-approval studies (Phase 4)Study completedNCT02577107
What this trial is testing

Head to Head Study of Anti-VEGF Treatment.

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 12
Not applicableStudy completedNCT02615496
What this trial is testing

Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept

Who this might be right for
Macular Degeneration
Bayer 716
Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557
Not applicableStudy completedNCT01447043
What this trial is testing

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Who this might be right for
Ophthalmology, Macular Degeneration
Bayer 2,609
Not applicableStudy completedNCT07235527
What this trial is testing

Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationExudative Age-Related Macular DegenerationAnti Vascular Endothelial Growth Factor
Saglik Bilimleri Universitesi 54
Testing effectiveness (Phase 2)Study completedNCT00733304
What this trial is testing

An Extension to Study MD7108240

Who this might be right for
Macular Degeneration
GlaxoSmithKline 42
Post-approval studies (Phase 4)UnknownNCT01857544
What this trial is testing

Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

Who this might be right for
Retinal Vein Occlusion
Tennessee Retina 10
Testing effectiveness (Phase 2)Study completedNCT00775411
What this trial is testing

Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 44
Not applicableStudy completedNCT01771081
What this trial is testing

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

Who this might be right for
OphthalmologyMacular EdemaMacular Degeneration
Bayer 911
Testing effectiveness (Phase 2)Study completedNCT01243086
What this trial is testing

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab

Who this might be right for
Wet Macular Degeneration
McMaster University 10
Large-scale testing (Phase 3)Study completedNCT00943072
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Macular Edema Secondary to Central Retinal Vein Occlusion
Regeneron Pharmaceuticals 189
Not applicableStudy completedNCT01350323
What this trial is testing

Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization

Who this might be right for
Age-related Macular Degeneration
University of Molise 33
Testing effectiveness (Phase 2)Study completedNCT02571972
What this trial is testing

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

Who this might be right for
Wet Macular DegenerationAge-related Macular DegenerationDiabetic Macular Edema+1 more
Wills Eye 14
Next Page